Form S-1


Also found in: Medical, Wikipedia.

Form S-1

A document filed with the SEC explaining an initial public offering of securities. Form S-1 must contain a complete description of the security and the terms of the sale. It must also include applicable information about the issuer's financial situation and applicable risk factors. This is done to protect investors from fraud.

Form S-1

A statement that a firm must file with the SEC before its securities can be listed for trading on a national securities exchange. This form contains information on the firm's business, financing, and directors. It also includes a description of the securities listed.
Mentioned in ?
References in periodicals archive ?
Bioelectronics company Nexeon MedSystems Inc stated on Wednesday that its Form S-1 resale registration statement (S-1) for the sale of 5,332,496 shares of the its common stock has been declared effective by the US Securities and Exchange Commission.
M2 PHARMA-June 27, 2016-Medpace Holdings files Form S-1 registration statement for proposed initial public offering for common stock
Edgen Group Inc, a distributor of specialty products to the energy sector, has filed a registration statement on Form S-1 with the US Securities and Exchange Commission.
Because there is no form specifically designed for the stand-alone GLB products, insurers and banks that want to offer the products must register the products using Form S-1, Roth writes.
NYSE:PVR), today announced that it will commence an initial public offering of 6,300,000 of its common units pursuant to a registration statement on Form S-1 previously filed with the Securities and Exchange Commission.
M2 EQUITYBITES-April 10, 2017-Biohaven files registration statement on Form S-1 with the US SEC
DAYTON, Ohio -- Dayton Superior Corporation ("Dayton Superior"), announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.
M2 EQUITYBITES-February 15, 2017-Great Basin Scientific files SEC registration statement on Form S-1
In addition, the Company has filed its quarterly reports on Form 10-Q for the periods ended March 31, 2006 and June 30, 2006 and its Form S-1 registration statement seeking registration of the common shares issued in private placements completed in July 2005, March 2006 and June 2006.
M2 EQUITYBITES-June 27, 2016-Medpace Holdings files Form S-1 registration statement for proposed initial public offering for common stock
Miller, which was expected as disclosed in the Company's Registration Statement on Form S-1.
M2 EQUITYBITES-November 26, 2015-Spark Therapeutics files registration statement on Form S-1 with the US Securities and Exchange Commission for planned public offering of common stock